98 related articles for article (PubMed ID: 27012115)
1. Tobacco smoking, paraoxonase-1 (PON1) activity and pleiotropic effects of simvastatin treatment in patients with stable coronary artery disease (CAD).
Januszek R
Przegl Lek; 2015; 72(11):597-605. PubMed ID: 27012115
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase-1 activity and pleiotropic properties of simvastatin in obese and non-obese patients with stable coronary artery disease (CAD).
Januszek R
Przegl Lek; 2016; 73(2):59-66. PubMed ID: 27197424
[TBL] [Abstract][Full Text] [Related]
3. [Smoking enhances the decrease of adiponectin level in patients with coronary artery disease, carriers of MTHFR 677T and PON1 55M alleles].
Strauss E; Radziemski A; Głuszek J; Pawlak A
Przegl Lek; 2010; 67(10):859-65. PubMed ID: 21360915
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase-1 and Simvastatin Treatment in Patients with Stable Coronary Artery Disease.
Januszek R
Int J Vasc Med; 2016; 2016():6312478. PubMed ID: 27213056
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
[TBL] [Abstract][Full Text] [Related]
6. The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.
Himbergen TM; van Tits LJ; Voorbij HA; de Graaf J; Stalenhoef AF; Roest M
J Intern Med; 2005 Nov; 258(5):442-9. PubMed ID: 16238680
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
[TBL] [Abstract][Full Text] [Related]
8. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
Ding J; Chen Q; Zhuang X; Feng Z; Xu L; Chen F
Med Sci Monit; 2014 Nov; 20():2421-9. PubMed ID: 25420483
[TBL] [Abstract][Full Text] [Related]
9. Human paraoxonase gene polymorphisms and coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
[TBL] [Abstract][Full Text] [Related]
10. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome.
Koubaa N; Nakbi A; Hammami S; Attia N; Mehri S; Ben Hamda K; Ben Farhat M; Miled A; Hammami M
Clin Biochem; 2009 Jun; 42(9):771-6. PubMed ID: 19269283
[TBL] [Abstract][Full Text] [Related]
11. Effect of statin therapy on plasma high-density lipoprotein-cholesterol levels is modified by paraoxonase 1 in Chinese patients with coronary heart disease.
Fu R; Sun YM; Su Y; Wu Y; Luan Y
Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):982-3. PubMed ID: 18430057
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients.
Sardo MA; Campo S; Bonaiuto M; Bonaiuto A; Saitta C; Trimarchi G; Castaldo M; Bitto A; Cinquegrani M; Saitta A
Curr Med Res Opin; 2005 May; 21(5):777-84. PubMed ID: 15969877
[TBL] [Abstract][Full Text] [Related]
13. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease.
Balcerzyk A; Zak I; Krauze J
Arch Med Res; 2007 Jul; 38(5):545-50. PubMed ID: 17560461
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.
Singh S; Venketesh S; Verma JS; Verma M; Lellamma CO; Goel RC
Indian J Med Res; 2007 Jun; 125(6):783-7. PubMed ID: 17704557
[TBL] [Abstract][Full Text] [Related]
16. Relationship between rs854560
Iwanicka J; Iwanicki T; Niemiec P; Nowak T; Krauze J; Grzeszczak W; Górczyńska-Kosiorz S; Ochalska-Tyka A; Żak I
Dis Markers; 2017; 2017():1540949. PubMed ID: 29118461
[TBL] [Abstract][Full Text] [Related]
17. Vascular effects of diet and statin in hypercholesterolemic patients.
Koh KK; Son JW; Ahn JY; Jin DK; Kim HS; Choi YM; Ahn TH; Kim DS; Shin EK
Int J Cardiol; 2004 Jun; 95(2-3):185-91. PubMed ID: 15193818
[TBL] [Abstract][Full Text] [Related]
18. Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities.
Shenhar-Tsarfaty S; Waiskopf N; Ofek K; Shopin L; Usher S; Berliner S; Shapira I; Bornstein NM; Ritov Y; Soreq H; Ben Assayag E
Eur J Neurol; 2013 Jun; 20(6):891-8. PubMed ID: 23305304
[TBL] [Abstract][Full Text] [Related]
19. The level of hs-CRP in coronary artery ectasia and its response to statin and angiotensin-converting enzyme inhibitor treatment.
Ozbay Y; Akbulut M; Balin M; Kayancicek H; Baydas A; Korkmaz H
Mediators Inflamm; 2007; 2007():89649. PubMed ID: 17497040
[TBL] [Abstract][Full Text] [Related]
20. Interactions between paraoxonase 1 genetic polymorphisms and smoking and their effects on oxidative stress and lung cancer risk in a Korean population.
Eom SY; Yim DH; Lee CH; Choe KH; An JY; Lee KY; Kim YD; Kim H
PLoS One; 2015; 10(3):e0119100. PubMed ID: 25741997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
